Description
Oxiracetam is a pyrrolidone-derived nootropic compound belonging to the racetam family. It is structurally related to piracetam, featuring an additional hydroxyl (-OH) group that enhances hydrophilicity and bioavailability in aqueous environments.
This compound interacts with cholinergic and glutamatergic pathways, influencing AMPA and NMDA receptor activity. It undergoes hepatic metabolism primarily through hydroxylation and conjugation, with excretion occurring predominantly via renal clearance.